MAPK3 and breast cancer: Indeed, activation phosphorylation of Erk1/2 is negatively correlated with the expression levels of RKIP in breast cancer cell lines “Fig 4B and 4C”and the invasive capacity of 4T1 was largely Erk1/2 signaling dependent Fig 4D.